Vaccine triggers HIV antibodies in monkeys

Scientists at the Scripps Research Institute developed a new HIV vaccine method that successfully prompted broadly neutralizing antibodies (bnAbs) in primates. This is a significant step toward developing effective HIV vaccines for humans. The research was published in Nature.